Dingwei Ye
- Cancer Research top 2%
- Urology top 1%
-
- Prostate Cancer Treatment and Research 42
- Prostate Cancer Diagnosis and Treatment 28
- Renal cell carcinoma treatment 22
- Ferroptosis and cancer prognosis 15
- Oncology top 5%
- Molecular Biology top 5%
-
- Bladder and Urothelial Cancer Treatments 29
- Genital Health and Disease 20
- Urinary and Genital Oncology Studies 16
-
- Urologic and reproductive health conditions 24
- Partner nations
- ChinaUnited StatesGermany
In The Last Decade
Dingwei Ye
146 papers receiving 3.2k citations
Peers
Comparison fields: 5 of 118
- Cancer Research 750
- Urology 272
- Pulmonary and Respiratory Medicine 1.1k
- Oncology 698
- Molecular Biology 1.6k
Countries citing papers authored by Dingwei Ye
This map shows the geographic impact of Dingwei Ye's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dingwei Ye with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dingwei Ye more than expected).
Fields of papers citing papers by Dingwei Ye
This network shows the impact of papers produced by Dingwei Ye. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dingwei Ye. The network helps show where Dingwei Ye may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Dingwei Ye, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 5 | |
| 2 | 2024 | 11 | |
| 3 | 2024 | 0 | |
| 4 | 2024 | 5 | |
| 5 | 2024 | 0 | |
| 6 | 2023 | 1 | |
| 7 | 2023 | 7 | |
| 8 | 2021 | 8 | |
| 9 | 2019 | 102 | |
| 10 | 2019 | 10 | |
| 11 | 2019 | 12 | |
| 12 | 2019 | 43 | |
| 13 | 2018 | 127 | |
| 14 | 2016 | 13 | |
| 15 | 2015 | 8 | |
| 16 | 2014 | 10 | |
| 17 | 2013 | 19 | |
| 18 | 2013 | 5 | |
| 19 | 2009 | 15 | |
| 20 | Progress in anti-angiogenesis targeted drugs | 2009 | 1 |
About Dingwei Ye
Dingwei Ye is a scholar working on Pulmonary and Respiratory Medicine, Urology, Cancer Research, Rheumatology and Oncology, having authored 151 papers that have together received 3.2k indexed citations. Recurring topics across this work include Prostate Cancer Treatment and Research (42 papers), Bladder and Urothelial Cancer Treatments (29 papers), Prostate Cancer Diagnosis and Treatment (28 papers), Urologic and reproductive health conditions (24 papers), Renal cell carcinoma treatment (22 papers), Genital Health and Disease (20 papers), Urinary and Genital Oncology Studies (16 papers) and Ferroptosis and cancer prognosis (15 papers). The work is most often cited by research in Cancer Research (750 citations), Urology (272 citations), Pulmonary and Respiratory Medicine (1.1k citations), Oncology (698 citations) and Molecular Biology (1.6k citations). Dingwei Ye has collaborated with scholars based in China, United States and Germany. Frequent co-authors include Yao Zhu, Bo Dai, Yijun Shen, Xu-Dong Yao, Bo Dai, Hai‐Liang Zhang, Shi-Lin Zhang, Guo-Hai Shi, Junlong Wu and Jy Zhang. Their work appears in journals such as Asian Journal of Andrology, Oncotarget, Scientific Reports, The Journal of Urology and Frontiers in Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.